SEC Form 4 · accession 0001104659-26-077775
Orchestra BioMed Holdings, Inc. · OBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pamela Ann Connealy
Director
Period of report
Jun 23, 2026
Accepted (ET)
Jun 25, 2026 · 4:18 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001814114
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share ("Common Stock")F1 | Jun 23, 2026 | A | 17,327 | $0.00 | A | 66,038 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $4.04 | Jun 23, 2026 | A | 21,277 | A | — | Jun 23, 2036 | Common Stock | 21,277 | 21,277 | D |
Explanation of responses
- F1Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 23, 2026 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date.
- F2The stock options will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date.